{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T01:40:22Z","timestamp":1776908422809,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijtb.2025.06.019","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:57:20Z","timestamp":1751421440000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Barriers and facilitators of adherence to anti-TB treatment in Western Indian population: A cross-sectional study"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2629-7094","authenticated-orcid":false,"given":"Richa","family":"Gwalani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seamone","family":"Baliyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhi","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarti","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijtb.2025.06.019_bib1","series-title":"INDIA TB REPORT 2022","year":"2023"},{"key":"10.1016\/j.ijtb.2025.06.019_bib2","series-title":"Global TB Report 2024","year":"2024"},{"key":"10.1016\/j.ijtb.2025.06.019_bib3","series-title":"India TB Report 2024","year":"2024"},{"issue":"2\u20133","key":"10.1016\/j.ijtb.2025.06.019_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/ijmr.ijmr_382_23","article-title":"The prevalence of tuberculosis infection in India: a systematic review and meta-analysis","volume":"157","author":"Chauhan","year":"2023","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijtb.2025.06.019_bib5","series-title":"India National TB Prevalence Survey Report (2019\u20132021)","author":"Kirakumar Rade","year":"2022"},{"key":"10.1016\/j.ijtb.2025.06.019_bib6","series-title":"Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India","year":"2017"},{"issue":"11","key":"10.1016\/j.ijtb.2025.06.019_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/tmi.13824","article-title":"Level of adherence to anti-tubercular treatment among drug-sensitive tuberculosis patients on a newly introduced daily dose regimen in South India: a cross-sectional study","volume":"27","author":"Thamineni","year":"2022","journal-title":"Trop Med Int Health"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.52314\/gjms.2021.v1i1.15","article-title":"Retrospective analysis of patients taking Anti-Koch\u2019s Treatment (AKT) in incidence of tuberculosis in the urban population of South Gujarat","volume":"1","author":"Patel","year":"2021","journal-title":"Glob J Med Stud"},{"issue":"5","key":"10.1016\/j.ijtb.2025.06.019_bib9","article-title":"Directly observed therapy for treating tuberculosis","volume":"2015","author":"Karumbi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijtb.2025.06.019_bib10","unstructured":"World Health Organization. Adherence to long-term therapies: evidence for action. Geneva WHO [no year mentioned]. Available from: https:\/\/iris.who.int\/handle\/10665\/42682."},{"key":"10.1016\/j.ijtb.2025.06.019_bib11","article-title":"Assessment of anti-TB drug nonadherence and associated factors among TB patients attending TB clinics in Arba Minch governmental health institutions, southern Ethiopia","author":"Gube","year":"2018","journal-title":"Tuberc Res Treat 2018"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1789-z","article-title":"Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study","volume":"15","author":"Tang","year":"2015","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib13","article-title":"Tuberculosis treatment adherence of patients in Kosovo","volume":"2017","author":"Krasniqi","year":"2017","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.ijtb.2025.06.019_bib14","article-title":"Patient non-adherence to tuberculosis treatment in Sudan: socio-demographic factors influencing non-adherence to tuberculosis therapy in Khartoum State","volume":"25","author":"Ali","year":"2016","journal-title":"Pan Afr Med J"},{"issue":"11","key":"10.1016\/j.ijtb.2025.06.019_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078791","article-title":"Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in Northwest Ethiopia","volume":"8","author":"Adane","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijtb.2025.06.019_bib16","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.4103\/jfmpc.jfmpc_2128_21","article-title":"\u201cI lost my faith and stopped taking the medicines\u201d \u2013 need for an intervention model based on health belief constructs for improving adherence to tuberculosis treatment","volume":"11","author":"Solanki","year":"2022","journal-title":"J Fam Med Prim Care"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-016-1545-9","article-title":"Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India","volume":"16","author":"Yellappa","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"10.1016\/j.ijtb.2025.06.019_bib18","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4103\/jfmpc.jfmpc_709_20","article-title":"Social stigma among tuberculosis patients attending DOTS centers in Delhi","volume":"9","author":"Kamble","year":"2020","journal-title":"J Fam Med Prim Care"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijtb.2023.03.005","article-title":"Counseling intervention improves treatment adherence among newly diagnosed drug sensitive Tuberculosis patients of Ahmedabad city \u2013 a mixed methods approach","volume":"71","author":"Raval","year":"2024","journal-title":"Indian J Tubercul"},{"key":"10.1016\/j.ijtb.2025.06.019_bib20","author":"Sequera"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s13104-018-3789-4","article-title":"Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia","volume":"11","author":"Mekonnen","year":"2018","journal-title":"BMC Res Notes"},{"issue":"7","key":"10.1016\/j.ijtb.2025.06.019_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002595","article-title":"Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies","volume":"15","author":"Alipanah","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijtb.2025.06.019_bib23","unstructured":"Varshney AM, Sukhdarshan UD. Sources of Previous Anti-tubercular Drugs Exposure for Patients Registered in RNTCP as Retreatment Cases in District Anand, Gujarat."},{"key":"10.1016\/j.ijtb.2025.06.019_bib24","unstructured":"Gohel H, Patel G, Shah E, Shah H, Dholakia H, Patel H. A cross-sectional study to assess the non-adherence to anti-tuberculosis treatment and determinant factors among patients with pulmonary tuberculosis. J Med Sci [Volume VI]."},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2141-9248.109507","article-title":"Non-adherence of new pulmonary tuberculosis patients to anti-tuberculosis treatment","volume":"3","author":"Kulkarni","year":"2013","journal-title":"Ann Med Health Sci Res"},{"key":"10.1016\/j.ijtb.2025.06.019_bib26","article-title":"Determinants of poor adherence to anti-tuberculosis treatment in Mumbai, India","volume":"1","author":"Bagchi","year":"2010","journal-title":"Int J Prev Med"},{"issue":"6","key":"10.1016\/j.ijtb.2025.06.019_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s12098-024-05131-z","article-title":"Prasad scale for socioeconomic status classification for the year 2024","volume":"91","author":"Akshithanand","year":"2024","journal-title":"Indian J Pediatr"},{"issue":"3","key":"10.1016\/j.ijtb.2025.06.019_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0975-7406.160034","article-title":"Assessment of treatment interruption among pulmonary tuberculosis patients: a cross-sectional study","volume":"7","author":"Gorityala","year":"2015","journal-title":"J Pharm BioAllied Sci"},{"key":"10.1016\/j.ijtb.2025.06.019_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1015024","article-title":"Why and where?\u2014delay in Tuberculosis care cascade: a cross-sectional assessment in two Indian states, Jharkhand, Gujarat","volume":"11","author":"Yasobant","year":"2023","journal-title":"Front Public Health"},{"issue":"4","key":"10.1016\/j.ijtb.2025.06.019_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5588\/pha.23.0019","article-title":"Health-seeking pathway of drug-resistant TB patients in Vadodara, India","volume":"13","author":"Sheth","year":"2023","journal-title":"Public Health Action"},{"key":"10.1016\/j.ijtb.2025.06.019_bib31","article-title":"Retreatment outcome of smear positive tuberculosis cases under DOTS in Bangalore City","volume":"49","author":"Vijay","year":"2002","journal-title":"Ind Tuberc"},{"key":"10.1016\/j.ijtb.2025.06.019_bib32","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.2147\/RMHP.S322143","article-title":"Contributing factors in the tuberculosis care cascade in India: a systematic literature review","volume":"14","author":"Yasobant","year":"2021","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/s42492-024-00154-x","article-title":"Convolutional neural network based data interpretable framework for Alzheimer's treatment planning","volume":"7","author":"Parvin","year":"2024","journal-title":"Vis Comput Ind Biomed Art"},{"issue":"4","key":"10.1016\/j.ijtb.2025.06.019_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/17441690802063205","article-title":"High adherence to anti-tuberculosis treatment among patients attending a hospital and slum health centre in Nairobi, Kenya","volume":"3","author":"Raguenaud","year":"2008","journal-title":"Glob Public Health"},{"key":"10.1016\/j.ijtb.2025.06.019_bib35","article-title":"Tuberculosis treatment non-adherence and lost to follow-up among TB patients with or without HIV in developing countries: a systematic review","year":"2015","journal-title":"Iran J Public Health"},{"issue":"3","key":"10.1016\/j.ijtb.2025.06.019_bib36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.47203\/IJCH.2020.v32i03.001","article-title":"Tuberculosis control programme from NTCP to RNTCP to NTEP","volume":"32","author":"Kumar","year":"2020","journal-title":"Indian J Community Health"},{"issue":"1","key":"10.1016\/j.ijtb.2025.06.019_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-023-08418-2","article-title":"Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijtb.2025.06.019_bib39","doi-asserted-by":"crossref","unstructured":"Saha SK, Adhikary A, Jha A, Mehta VK. Use of interventions to overcome medication non-adherence. Int J Appl Behav Inform 1AD; 12(3):289\u2013318. https:\/\/www.igi-global.com\/article\/use-of-interventions-to-overcome-medication-non-adherence\/279823.","DOI":"10.4018\/IJABIM.20210701.oa18"},{"key":"10.1016\/j.ijtb.2025.06.019_bib40","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.12688\/f1000research.125815.1","article-title":"Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India","volume":"11","author":"Shah","year":"2022","journal-title":"F1000Research"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570725001453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:04:53Z","timestamp":1776877493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570725001453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0019570725001453"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.06.019","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers and facilitators of adherence to anti-TB treatment in Western Indian population: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2025.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Tuberculosis Association of India. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}